SUN PHARMA ADVANCED RESEARCH C (SPARC)

Current Price: ₹0.00

Back to Home
Stock Performance

Quarterly Financials

Consolidated Standalone
Particulars Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025
Revenue from Operations 21.18 13.86 16.56 16.81 12.86 14.91 27.19 9.64 7.86 8.45
YOY Revenue Growth % - - - - -39.28% 7.58% 64.19% -42.65% -38.88% -43.33%
Other Income 8.49 6.39 4.40 1.56 0.04 0.19 0.00 9.14 0.01 0.00
Total Income 29.67 20.25 20.96 18.37 12.90 15.10 27.19 18.78 7.87 8.45
Total Expenses + 112.65 116.48 122.39 110.17 115.77 88.60 87.86 70.59 83.66 76.44
Cost of Materials Consumed 6.47 9.03 7.46 4.53 8.31 4.58 5.70 5.13 6.10 7.21
Employee Benefit Expense 30.71 29.98 50.03 54.26 38.48 30.99 29.85 31.32 29.51 31.18
Other Expenses 75.47 77.47 64.90 51.38 68.98 53.03 44.82 25.27 37.97 26.70
Operating Profit -91.47 -102.62 -105.83 -93.36 -102.91 -73.69 -60.67 -60.95 -75.80 -67.99
OPM % -431.9% -740.4% -639.1% -555.4% -800.2% -494.2% -223.1% -632.3% -964.4% -804.6%
Profit Before Tax + -86.42 -99.65 -105.41 -95.50 -107.17 -79.44 -60.67 -51.81 -75.79 -80.35
Tax Expense 0.00 0.00 0.38 0.40 0.16 0.07 -0.90 0.06 0.06 0.07
Tax % - - - - - - - - - -
Profit After Tax -86.42 -99.65 -105.79 -95.90 -107.33 -79.51 -59.77 -51.87 -75.85 -80.42
EPS (Basic) -2.66 -3.07 -3.26 -2.96 -3.31 -2.45 -1.84 -1.60 -2.34 -2.48

Yearly Financial Results

Consolidated Standalone
Particulars Mar 2025 Mar 2024
Revenue from Operations 71.77 75.55
YOY Revenue Growth % -5% -
Other Income 1.79 29.47
Total Income 73.56 105.02
Total Expenses + 416.34 477.65
Cost of Materials Consumed 23.12 28.13
Employee Benefit Expense 153.58 141.84
Other Expenses 218.21 307.68
Operating Profit -344.57 -402.10
OPM % -480.1% -532.2%
Profit Before Exceptional -342.78 -386.83
Exceptional Items 0.00 0.00
Profit Before Tax + -342.78 -386.83
Tax Expense -0.27 0.38
Tax % - -
Profit After Tax -342.51 -387.21
EPS (Basic) -10.55 -11.93

Balance Sheet

Particulars Mar 2025 Mar 2024
ASSETS
Non-Current Assets + 309.34 245.66
Property, Plant & Equipment 98.70 107.35
Capital Work in Progress 0.56 1.26
Non-Current Investments 0.00 0.00
Goodwill 0.00 0.00
Other Intangible Assets 0.06 0.19
Current Assets + 26.19 269.38
Inventories 0.00 0.00
Trade Receivables 16.06 15.53
Cash and Cash Equivalents 1.96 5.33
Current Investments 0.00 1.80
LIABILITIES & EQUITY
Total Equity 0.00 0.00
Equity Share Capital 32.45 32.45
Other Equity -249.40 93.30
Non-Current Liabilities 178.24 124.24
Current Liabilities 374.24 265.05
Total Liabilities 552.48 389.29

Cash Flow Statement

Particulars Mar 2025 Mar 2024
Cash from Operating Activities -360.29 -429.20
Cash from Investing Activities 157.66 391.53
Cash from Financing Activities 199.25 42.42
Net Increase/Decrease in Cash -3.37 4.75